T

Thorne Healthtech Inc
F:F7G

Watchlist Manager
Thorne Healthtech Inc
F:F7G
Watchlist
Price: 9.25 EUR -3.14% Market Closed
Market Cap: 499.8m EUR
Section:
 

Relative Value

The Relative Value of one F7G stock under the Base Case scenario is hidden EUR. Compared to the current market price of 9.25 EUR, Thorne Healthtech Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

F7G Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
54
vs Industry
31
Median 3Y
1.6
Median 5Y
1.5
Industry
1.1
Forward
1.9
More Details
9.9
P/E
P/E
Price to Earnings
9.9
vs History
28
vs Industry
32
Median 3Y
8.9
Median 5Y
7.4
Industry
17.8
Forward
9.6
More Details
5
P/OCF
P/OCF
Price to OCF
5
vs History
76
vs Industry
54
Median 3Y
8.7
Median 5Y
7.6
Industry
11.6
More Details
13.2
P/FCFE
P/FCFE
Price to FCFE
13.2
vs History
14
vs Industry
17
Median 3Y
-5
Median 5Y
2.8
Industry
15.6
More Details
0.5
P/B
P/B
Price to Book Value
0.5
vs History
7
vs Industry
78
Median 3Y
0.5
Median 5Y
0.5
Industry
1.5
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
90
vs Industry
15
Median 3Y
3.6
Median 5Y
3.2
Industry
1.2
Forward
3.7
More Details
5.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.8
vs History
92
vs Industry
22
Median 3Y
7.9
Median 5Y
7.2
Industry
4
More Details
7.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.1
vs History
92
vs Industry
39
Median 3Y
9.9
Median 5Y
8.9
Industry
10.4
Forward
9
More Details
7.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
7.2
vs History
92
vs Industry
46
Median 3Y
10
Median 5Y
9
Industry
13.5
More Details
9.5
EV/OCF
EV/OCF
Enterprise Value to OCF
9.5
vs History
80
vs Industry
36
Median 3Y
18.3
Median 5Y
19.5
Industry
12.5
More Details
10.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
10.4
vs History
74
vs Industry
31
Median 3Y
22.6
Median 5Y
25.8
Industry
15.7
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
36
vs Industry
69
Median 3Y
0.6
Median 5Y
0.6
Industry
1.2
More Details

Multiples Across Competitors

F7G Competitors Multiples
Thorne Healthtech Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Thorne Healthtech Inc
F:F7G
499.8m EUR 1.5 9.9 7.1 7.2
FR
L'Oreal SA
PAR:OR
205.6B EUR 4.7 33.6 19 23.2
UK
Unilever PLC
LSE:ULVR
116.2B GBP 2.2 23.3 201.7 234.4
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.6T INR 8.7 51.2 37.1 41.1
UK
HALEON PLC
LSE:HLN
33.2B GBP 3 23 13.9 15.8
US
Estee Lauder Companies Inc
NYSE:EL
40.7B USD 2.8 -43.8 22 36.3
DE
Beiersdorf AG
XETRA:BEI
20.8B EUR 2.1 23.6 11.6 14.9
JP
Kao Corp
TSE:4452
2.9T JPY 1.7 23.7 11.3 17.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 8.5 69 42.9 47
IN
Dabur India Ltd
NSE:DABUR
925.9B INR 7.2 51.2 38.4 47.6
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 855.7 -4 624.4 -6 373.4 -6 360.4
P/E Multiple
Earnings Growth PEG
US
T
Thorne Healthtech Inc
F:F7G
Average P/E: 34.3
9.9
N/A N/A
FR
L'Oreal SA
PAR:OR
33.6
8%
4.2
UK
Unilever PLC
LSE:ULVR
23.3
15%
1.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
51.2
8%
6.4
UK
HALEON PLC
LSE:HLN
23
12%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -43.8 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
23.6
8%
2.9
JP
Kao Corp
TSE:4452
23.7
13%
1.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
69
19%
3.6
IN
Dabur India Ltd
NSE:DABUR
51.2
12%
4.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
T
Thorne Healthtech Inc
F:F7G
Average EV/EBITDA: 40.5
7.1
N/A N/A
FR
L'Oreal SA
PAR:OR
19
5%
3.8
UK
Unilever PLC
LSE:ULVR
201.7
1%
201.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
37.1
8%
4.6
UK
HALEON PLC
LSE:HLN
13.9
4%
3.5
US
Estee Lauder Companies Inc
NYSE:EL
22
15%
1.5
DE
Beiersdorf AG
XETRA:BEI
11.6
-1%
N/A
JP
Kao Corp
TSE:4452
11.3
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
42.9
13%
3.3
IN
Dabur India Ltd
NSE:DABUR
38.4
11%
3.5
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 373.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
T
Thorne Healthtech Inc
F:F7G
Average EV/EBIT: 48.5
7.2
N/A N/A
FR
L'Oreal SA
PAR:OR
23.2
6%
3.9
UK
Unilever PLC
LSE:ULVR
234.4
1%
234.4
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
41.1
9%
4.6
UK
HALEON PLC
LSE:HLN
15.8
4%
3.9
US
Estee Lauder Companies Inc
NYSE:EL
36.3
25%
1.5
DE
Beiersdorf AG
XETRA:BEI
14.9
-2%
N/A
JP
Kao Corp
TSE:4452
17.3
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
47
13%
3.6
IN
Dabur India Ltd
NSE:DABUR
47.6
11%
4.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 360.4 N/A N/A

See Also

Summary
F7G intrinsic value, competitors valuation, and company profile.
DCF Valuation
F7G stock valuation using Discount Cash Flow valuation method.
Relative Valuation
F7G stock valuation using valuation multiples.
Wall Street Estimates
F7G price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
F7G stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.